PatinaInsurance

09/09/2026

08/12/2026

Nationwide Recall due to glass particles in medication😳

FOR IMMEDIATE RELEASE – August 10, 2026 – LAKE ZURICH, Ill.— Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 mL vials to the user level. An internal investigation at the firm found the product ...

07/29/2026

"Tomorrow's Concerns, Today's Certainties."

The landmark law created a network of community-based support programs for older adults in the U.S.

07/21/2026

"Tomorrow's Concerns, Today's Certainties."

Medicare Advantage already has out-of-pocket limits

07/21/2026

"Tomorrow's Concerns, Today's Certainties."

“Bad” cholesterol isn’t just a heart concern; it’s a brain issue. Taking steps to lower LDL may help protect both body and mind

07/21/2026

"Tomorrow's Concerns, Today's Certainties."

Summer is in full swing — make sure you know the signs of heat-related illness! If you’re outside and start feeling dizzy, weak, or nauseated, go inside or seek help. Learn how to stay safe in the heat: https://go.medicare.gov/4pa9GIg

07/21/2026

Unique Pharmaceutical Laboratories Issues Voluntary of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine
https://www.drugs.com/fda/unique-pharmaceutical-laboratories-issues-voluntary-nationwide-recall-cetirizine-hydrochloride-usp-14818.html?hash2=5ec84a3eecae5b6377f0b7729dc8c76f&utm_source=ddc&utm_medium=email&utm_campaign=FDA+Safety+Alert++Unique+Pharmaceutical+Laboratories+Issues+Voluntary+Nationwide+Recall+of+Cetirizine+Hydrochloride+Tablets+USP+5+mg+Due+to+Potential+Cross+Contamination+with+Ranitidine

07/13/2026

July is National Blueberry Month! Blueberries are nutrient-dense and a great source of fiber, vitamin C, and vitamin K, so add them as part of a balanced diet.

07/13/2026

FDA Alerts Health Care Providers to Cases of Neurologic Complications Linked to Genetic Variant in Patients of Maternal Venezuelan Ancestry.

July 2, 2026 -- The U.S. Food and Drug Administration (FDA) is investigating the safety of sevoflurane and other general anesthetics based on published scientific reports of unexpected catastrophic outcomes, including severe neurologic adverse outcomes and death, occurring in adult and pediatric pat...

07/03/2026

Making decisions about health and life insurance is a careful process. That’s why it’s important for employers and their employees to consider the advantages of Employer Group Benefits and the positive impact they may have.

Learn more about our Employer Group Benefits on the ManhattanLife website at: https://www.manhattanlife.com/products/employers

You can also email us at [email protected]